Publications in collaboration with researchers from University Hospital of Zurich (1)

2020

  1. CDCP1 overexpression drives prostate cancer progression and can be targeted in vivo

    Journal of Clinical Investigation, Vol. 130, Núm. 5, pp. 2435-2450